Annual Results Results Snapshot
Figures in Cr
Standalone Annual Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Mar'19
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2025 is 2.24% vs 22.66% in Mar 2024
Standalone Net Profit
YoY Growth in year ended Mar 2025 is -21.16% vs 66.00% in Mar 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2025 is -18.95% vs 46.53% in Mar 2024
Interest
YoY Growth in year ended Mar 2025 is 77.14% vs 59.09% in Mar 2024
Operating Profit Margin (Excl OI)
YoY Growth in year ended Mar 2025 has fallen from Mar 2024
Compare Annual Results Of Anuh Pharma With
Figures in Cr
Standalone Annual Results
Change(INR)
Change(%)
Net Sales
661.51
304.13
357.38
117.51%
Other Operating Income
0.00
0.00
0.00
Total Operating income
661.51
304.13
357.38
117.51%
Raw Material Cost
463.28
178.34
284.94
159.77%
Purchase of Finished goods
38.55
1.13
37.42
3,311.50%
(Increase) / Decrease In Stocks
-2.45
10.14
-12.59
-124.16%
Employee Cost
23.04
21.38
1.66
7.76%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
-0.01
0.00
-0.01
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
78.20
59.55
18.65
31.32%
Total Expenditure (Excl Depreciation)
600.61
270.54
330.07
122.00%
Operating Profit (PBDIT) excl Other Income
60.90
33.59
27.31
81.30%
Other Income
9.46
14.55
-5.09
-34.98%
Operating Profit (PBDIT)
70.36
48.14
22.22
46.16%
Interest
0.62
4.79
-4.17
-87.06%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
69.74
43.35
26.39
60.88%
Depreciation
8.74
7.05
1.69
23.97%
Profit Before Tax
61.01
36.30
24.71
68.07%
Tax
13.65
9.85
3.80
38.58%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
47.35
26.45
20.90
79.02%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
47.35
26.45
20.90
79.02%
Equity Capital
25.06
6.89
18.17
263.72%
Face Value
5.00
10.00
0.00
Reserves
300.97
379.93
-78.96
-20.78%
Earnings per share (EPS)
4.72
38.39
-33.67
-87.71%
Diluted Earnings per share
4.72
40.36
-35.64
-88.31%
Operating Profit Margin (Excl OI)
9.21%
11.04%
0.00
-1.83%
Gross Profit Margin
10.54%
14.25%
0.00
-3.71%
PAT Margin
7.16%
8.70%
0.00
-1.54%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Annual - Net Sales
Net Sales 661.51 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 2.24% vs 22.66% in Mar 2024
Annual - Standalone Net Profit
Standalone Net Profit 47.35 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -21.16% vs 66.00% in Mar 2024
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 60.90 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -18.95% vs 46.53% in Mar 2024
Annual - Interest
Interest 0.62 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 77.14% vs 59.09% in Mar 2024
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 9.21%
in Mar 2025Figures in %
YoY Growth in year ended Mar 2025 has fallen from Mar 2024
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
